Table 4.
Preliminary results of clinical trial outcomes.
| Outcome measure/group | T1 | T2 | Comparison T1-T2 | |
|---|---|---|---|---|
| 95% IC | Cohen’s d | |||
| Pain Severity (BPI, points) | ||||
| - EI | 3.58 (2.29) | 2.83 (2.94) | −0.45 to 1.95 | 0.28 |
| - CI | 3.75 (2.32) | 3.88 (2.14) | −1.08 to 1.33 | −0.06 |
| Pain Interference (BPI, points) | ||||
| - EI | 4.14 (3.31) | 3.60 (3.83) | −0.98 to 2.07 | 0.15 |
| - CI | 4.24 (2.36) | 3.83 (2.23) | −1.12 to 1.93 | 0.17 |
| Tibialis anterior Mean Strength (Newtons) | ||||
| - EI | 38.91 (42.98) | 68.06 (69.34) | −56.29 to −2.02 | −0.51 |
| - CI | 43.95 (37.71) | 48.98 (49.66) | −32.168 to 22.11 | −0.11 |
| Quadriceps Mean Strength (Newtons) | ||||
| - EI | 90.17 (43.46) | 104.70 (65.03) | −55.202 to 26.15 | −0.26 |
| - CI | 77.91 (41.44) | 71.97 (43.97) | −34.73 to 46.62 | 0.14 |
| Tibialis anterior Maximum Strength (Newtons) | ||||
| - EI | 39.76 (42.77) | 71.54 (69.60) | −60.67 to −2.90 | -0.18 |
| - CI | 47.05 (39.00) | 53.53 (53.02) | −35.36 to 22.41 | −0.14 |
| Quadriceps Maximum Strength (Newtons) | ||||
| - EI | 94.45 (44.08) | 111.39 (62.98) | −58.78 to 24.89 | −0.31 |
| - CI | 84.87 (42.91) | 78.46 (46.24) | −35.42 to 48.24 | 0.14 |
| Walking speed (10MWT, s) | ||||
| - EI | 14.33 (7.75) | 10.88 (5.44) | 0.90 to 6.00 | 0.52 |
| - CI | 11.97 (4.35) | 9.71 (4.12) | −0.294 to 4.80 | 0.53 |
| Walking ability (WISCI, points) | ||||
| - EI | 17.5 (2.67) | 18.83 (1.83) | −2.51 to −0.159 | 0.13 |
| - CI | 16.67 (5.93) | 16.33 (6.71) | −0.84 to 1.51 | 0.05 |
Data are expressed in mean (SD).
BPI Brief Pain Inventory, CI Control Intervention, EI Experimental Intervention, WISCI Walking Index for Spinal Cord Injury, 10MWT 10 m walking test.
*p < 0.05 in bold.